Exact Mass: 532.1773802
Exact Mass Matches: 532.1773802
Found 324 metabolites which its exact mass value is equals to given mass value 532.1773802
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Flavonol 3-O-D-xylosylglycoside
Sesaminol glucoside
Sesaminol glucoside is found in cereals and cereal products. Sesaminol glucoside is a constituent of sesame seed. Constituent of sesame seed. Sesaminol glucoside is found in cereals and cereal products.
Ponatinib
C29H27F3N6O (532.2198328000001)
Ponatinib is a Bcr-Abl tyrosine kinase inhibitor that is especially effective against the T315I mutation for the treatment of chronic myeloid leukemia. FDA approved on December 14, 2012 (DB08901). L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163790 - Flt-3-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
3-[3-[4-[5-(2-Carboxyethyl)-2-hydroxyphenyl]-1,4-bis(carboxymethylamino)butyl]-4-hydroxyphenyl]propanoic acid
Plevitrexed
C26H25FN8O4 (532.1982701999999)
Isoscutellarein 4-methyl ether 8-(6-n-butylglucuronide)
2-O-(2-Methylbutyryl)orientin
Luteolin 7-[6-(2-methylbutyryl)glucoside]
4-Hydroxyrottlerin
5,7-Dihydroxy-6-C-methylflavone 7-xylosyl- (1->3) -xyloside
4-[(beta-D-glucopyranosyl)oxy]-2-(hydroxymethyl)-3-(3-methylbut-2-en-1-yl)phenyl beta-D-glucopyranoside|clemomandshuricoside C
(5E,7R,8R,14Z)-7-Acetoxy-10-iodo-12-hydroxy-9-oxoprosta-5,10,14-triene-1-oic acid methyl ester
5,4-dihydroxy-3-methoxyflavone-7-O-6-n-butyryl-beta-D-glucopyranoside|luteolin-3-O-methyl-7-O-(6-butyryl-beta-glucopyranoside)
6-gamma,gamma-dimethylallylquercetin 7-O-beta-D-glucoside
5-methoxy-6-methyl-7-[O-beta-D-glucopyranoside]- 8-aldehydo-3-(3,4-methylenedioxybenzyl)chroman-4-one|ophiopogoside B
(2E)-22-demethyl-2,3-didehydro-3-deoxy-maytansinol|(3E,5E,7R,84S,12E)-14-chloro-10t,11c-epoxy-84-hydroxy-15,7r-dimethoxy-3,9c,11t-trimethyl-(84rH,86cH)-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5,12-triene-82,14-dione|Normaysin|Normaysin (6)|normaysine
1alpha-acetoxy-6beta,9beta-difuroyloxy-2alpha,4beta-dihydroxy-dihydro-beta-agarofuran
3,3-dioxo-6,11,6,11-tetrahydro-5H,5H-[2,2]bi[indolizino[8,7-b]indolylidene]-5,5-dicarboxylic acid|Trichotomin|Trichotomine
7,8-dihydroxy-5-methoxycoumarin-7-beta-sophoroside
1-[6-[(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-5,7-dihydroxy-2,2-dimethylchromen-8-yl]-3-(4-hydroxyphenyl)prop-2-en-1-one
benzyl-7-O-(5-O-trans-cinnamoyl-beta-D-apiosyl)-(1->3)-beta-D-glucopyranoside
6-C-beta-D-glucopyranosyl-8-C-alpha-L-arabinosylapigenin|schaftside
6-C-alpha-L-arabinosyl-8-C-beta-D-glucopyranosylapigenin
3-[gamma-hydroxymethyl-(z)-gamma-methylallyl]-2,4,2,4-tetrahydroxychalcone 11-O-ferulate|gemichalcone C
1-O-(E)-feruloyl-(beta-<1->2>-glucuronosyl)-beta-glucose|1-O-(E)-feruloyl-[beta-(1->2)-glucuronosyl]-beta-glucose
Asn Asp Glu Arg
Asp His Phe Asp
5,7-Dihydroxy-6-C-methylflavone 7-xylosyl-(1->3)-xyloside
1-O-Deacetyl-2α-hydroxykhayanolide E
Cys Phe Thr Tyr
C25H32N4O7S (532.1991601999999)
Cys Phe Tyr Thr
C25H32N4O7S (532.1991601999999)
Cys His His His
Cys Pro Gln Trp
Cys Pro Trp Gln
Cys Gln Pro Trp
Cys Gln Trp Pro
Cys Thr Phe Tyr
C25H32N4O7S (532.1991601999999)
Cys Thr Tyr Phe
C25H32N4O7S (532.1991601999999)
Cys Trp Pro Gln
Cys Trp Gln Pro
Cys Tyr Phe Thr
C25H32N4O7S (532.1991601999999)
Cys Tyr Thr Phe
C25H32N4O7S (532.1991601999999)
Asp Asp Phe His
Asp Asp His Phe
Asp Asp Gln Arg
Asp Asp Arg Gln
Asp Glu Asn Arg
Asp Glu Arg Asn
Asp Phe Asp His
Asp Phe His Asp
Asp His Asp Phe
Asp His Met Met
Asp Met His Met
Asp Met Met His
Asp Asn Glu Arg
Asp Asn Arg Glu
Asp Gln Asp Arg
Asp Gln Arg Asp
Asp Arg Asp Gln
Asp Arg Glu Asn
Asp Arg Asn Glu
Asp Arg Gln Asp
Glu Asp Asn Arg
Glu Asp Arg Asn
Glu Glu Gln Gln
C20H32N6O11 (532.2128961999999)
Glu Asn Asp Arg
Glu Asn Arg Asp
Glu Gln Glu Gln
C20H32N6O11 (532.2128961999999)
Glu Gln Gln Glu
C20H32N6O11 (532.2128961999999)
Glu Arg Asp Asn
Glu Arg Asn Asp
Phe Cys Thr Tyr
C25H32N4O7S (532.1991601999999)
Phe Cys Tyr Thr
C25H32N4O7S (532.1991601999999)
Phe Asp Asp His
Phe Asp His Asp
Phe His Asp Asp
Phe Thr Cys Tyr
C25H32N4O7S (532.1991601999999)
Phe Thr Tyr Cys
C25H32N4O7S (532.1991601999999)
Phe Tyr Cys Thr
C25H32N4O7S (532.1991601999999)
Phe Tyr Thr Cys
C25H32N4O7S (532.1991601999999)
Gly Met Tyr Tyr
C25H32N4O7S (532.1991601999999)
Gly Tyr Met Tyr
C25H32N4O7S (532.1991601999999)
Gly Tyr Tyr Met
C25H32N4O7S (532.1991601999999)
His Cys His His
His Asp Asp Phe
His Asp Phe Asp
His Asp Met Met
His Phe Asp Asp
His His Cys His
His His His Cys
His Met Asp Met
His Met Met Asp
Met Asp His Met
Met Asp Met His
Met Gly Tyr Tyr
C25H32N4O7S (532.1991601999999)
Met His Asp Met
Met His Met Asp
Met Met Asp His
Met Met His Asp
Met Tyr Gly Tyr
C25H32N4O7S (532.1991601999999)
Met Tyr Tyr Gly
C25H32N4O7S (532.1991601999999)
Asn Asp Arg Glu
Asn Glu Asp Arg
Asn Glu Arg Asp
Asn Arg Asp Glu
Asn Arg Glu Asp
Pro Cys Gln Trp
Pro Cys Trp Gln
Pro Gln Cys Trp
Pro Gln Trp Cys
Pro Trp Cys Gln
Pro Trp Gln Cys
Gln Cys Pro Trp
Gln Cys Trp Pro
Gln Asp Asp Arg
Gln Asp Arg Asp
Gln Glu Glu Gln
C20H32N6O11 (532.2128961999999)
Gln Glu Gln Glu
C20H32N6O11 (532.2128961999999)
Gln Pro Cys Trp
Gln Pro Trp Cys
Gln Gln Glu Glu
C20H32N6O11 (532.2128961999999)
Gln Arg Asp Asp
Gln Trp Cys Pro
Gln Trp Pro Cys
Arg Asp Asp Gln
Arg Asp Glu Asn
Arg Asp Asn Glu
Arg Asp Gln Asp
Arg Glu Asp Asn
Arg Glu Asn Asp
Arg Asn Asp Glu
Arg Asn Glu Asp
Arg Gln Asp Asp
Ser Thr Tyr Tyr
Ser Tyr Thr Tyr
Ser Tyr Tyr Thr
Thr Cys Phe Tyr
C25H32N4O7S (532.1991601999999)
Thr Cys Tyr Phe
C25H32N4O7S (532.1991601999999)
Thr Phe Cys Tyr
C25H32N4O7S (532.1991601999999)
Thr Phe Tyr Cys
C25H32N4O7S (532.1991601999999)
Thr Ser Tyr Tyr
Thr Tyr Cys Phe
C25H32N4O7S (532.1991601999999)
Thr Tyr Phe Cys
C25H32N4O7S (532.1991601999999)
Thr Tyr Ser Tyr
Thr Tyr Tyr Ser
Trp Cys Pro Gln
Trp Cys Gln Pro
Trp Pro Cys Gln
Trp Pro Gln Cys
Trp Gln Cys Pro
Trp Gln Pro Cys
Tyr Cys Phe Thr
C25H32N4O7S (532.1991601999999)
Tyr Cys Thr Phe
C25H32N4O7S (532.1991601999999)
Tyr Phe Cys Thr
C25H32N4O7S (532.1991601999999)
Tyr Phe Thr Cys
C25H32N4O7S (532.1991601999999)
Tyr Gly Met Tyr
C25H32N4O7S (532.1991601999999)
Tyr Gly Tyr Met
C25H32N4O7S (532.1991601999999)
Tyr Met Gly Tyr
C25H32N4O7S (532.1991601999999)
Tyr Met Tyr Gly
C25H32N4O7S (532.1991601999999)
Tyr Ser Thr Tyr
Tyr Ser Tyr Thr
Tyr Thr Cys Phe
C25H32N4O7S (532.1991601999999)
Tyr Thr Phe Cys
C25H32N4O7S (532.1991601999999)
Tyr Thr Ser Tyr
Tyr Thr Tyr Ser
Tyr Tyr Gly Met
C25H32N4O7S (532.1991601999999)
Tyr Tyr Met Gly
C25H32N4O7S (532.1991601999999)
Tyr Tyr Ser Thr
Tyr Tyr Thr Ser
galactan
Sesaminol glucoside
7-Acetoxy-7,8-dihydroiodovulone I
7-Acetoxy-7,8-dihydroiodovulone II
Plevitrexed
C26H25FN8O4 (532.1982701999999)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor D000970 - Antineoplastic Agents
4-NITROBENZYL (2S,4S)-4-ACETYLTHIO-2-((N-SULFAMOYL-N-(TERT-BUTOXYCARBONYL)AMINO)METHYL)PYRROLIDINE-1-CARBOXYLATE
C20H28N4O9S2 (532.1297638000001)
n6-(6-aminohexyl)adenosine 2,5-diphosphate lithium salt
bis(trimethylsilyl)tributyltinphosphate
C18H45O4PSi2Sn (532.1615850000001)
Oprozomib
C25H32N4O7S (532.1991601999999)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor C471 - Enzyme Inhibitor
4,6-bis(3-(2-ethylhexyl)thien-2-yl)thieno[3,4-c][1,2,5]thiadiazole
C28H40N2S4 (532.2074200000001)
Onvansertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C177899 - PLK1 Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Regrelor
C22H25N6O8P (532.1471419999999)
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists
2-Hydroxystilbamidine isethionate
C20H28N4O9S2 (532.1297638000001)
Benzamide, 4-methyl-N-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1,2,4-triazolo(4,3-a)pyridin-3-yl)ethynyl)-
C29H27F3N6O (532.2198328000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Pirbenicillin sodium
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
N2,N7-Bis(2,5-dimethylphenyl)-9H-fluorene-2,7-disulfonamide
C29H28N2O4S2 (532.1490408000001)
Ponatinib
C29H27F3N6O (532.2198328000001)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163790 - Flt-3-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
longipedumin A
A lignan isolated from the roots and stems of Kadsura longipedunculata and has been shown to exhibit inhibitory activity against HIV-1 protease.
(2R,3R)-5,5,6,6,8,8-hexahydroxy-2,2,3-trimethyl-2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione
2-(2-chlorophenyl)-N-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)phenyl]-4-quinolinecarboxamide
2-(4-Acetoxy-3-ethoxy-benzylidene)-7-methyl-3-oxo-5-styryl-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid ethyl ester
flavonol 3-O-D-xylosyl-D-galactoside
A glycosyloxyflavone that consists of flavonol attached to a D-xylosyl-D-galactosyl residue at position 3 via a glycosidic linkage.
3-chloro-N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
3-chloro-N-[(2S)-1-hydroxypropan-2-yl]-N-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
3-chloro-N-[(2R)-1-hydroxypropan-2-yl]-N-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
2-[(3S,6aS,8R,10aS)-1-(3,5-dichlorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
C27H30Cl2N2O5 (532.1531669999999)
3-chloro-N-[(2R)-1-hydroxypropan-2-yl]-N-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
3-chloro-N-[(2S)-1-hydroxypropan-2-yl]-N-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
3-chloro-N-[(2S)-1-hydroxypropan-2-yl]-N-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3S,6aS,8S,10aS)-1-[(3,5-dichlorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
C27H30Cl2N2O5 (532.1531669999999)
2-[(3R,6aR,8R,10aR)-1-[(3,5-dichlorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
C27H30Cl2N2O5 (532.1531669999999)
(1S)-N-(4-fluorophenyl)-1-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[[(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-fluoro-N-methylbenzenesulfonamide
3-chloro-N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
3-chloro-N-[(2S)-1-hydroxypropan-2-yl]-N-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3R,6aR,8S,10aR)-1-[(3,5-dichlorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
C27H30Cl2N2O5 (532.1531669999999)
(1R)-N-(2-fluorophenyl)-1-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-N-(4-fluorophenyl)-1-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
flavonol 3-O-D-xylosyl-D-glucoside
A glycosyloxyflavone that consists of flavonol attached to a D-xylosyl-D-glucosyl residue at position 3 via a glycosidic linkage.
7-(2-Hydroxy-3-amino-3-carboxypropyl)wyosine 5-monophosphate
6-[4-[6-Carboxy-5-(2,6-dihydroxyphenyl)-3-methylcyclohex-3-en-1-yl]-3-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
3,4,5-Trihydroxy-6-[[4-hydroxy-7-methoxy-2,2-dimethyl-6-(3-phenylpropanoyl)-3,4-dihydrochromen-5-yl]oxy]oxane-2-carboxylic acid
8-[1-(2,4-dihydroxyphenyl)-2-hydroxy-3-(3-hydroxyphenyl)propyl]-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol
sesaminol 2-O-beta-D-glucoside
A beta-D-glucoside that is sesaminol in which the hydroxy group at position 5 is substituted by a beta-D-glucopyranoside group. A metabolite found in sesame seeds.
chaetochromin C
A biaryl that is 2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione substituted by hydroxy groups at positions 5, 5, 6, 6, 8 and 8 and methyl groups at positions 2, 2 and 3 (the 2R,3R stereoisomer). It has been isolated from Chaetomium gracile.
cercosporin(2-)
A phenolate anion resulting from the deprotonation of the two hydroxy groups at position 5 and 12 of cercosporin. Major microspecies at pH 7.3.
IPN60090
IPN-60090 is an orally active and highly selective inhibitor of glutaminase 1?(GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 can be used for solid tumors research, such as lung and ovarian cancers[1][2].